PathMD

PathMD

Search
Skip to content
  • Immunohistochemistry
  • WHO Heme Classification
  • CK7 / CK20 Tables
  • Organ Systems
  • About

Myelodysplastic Syndromes (MDS)

  • Myelodysplastic Syndrome with Single Lineage Dysplasia (MDS-SLD)
  • Myelodysplastic Syndrome with Multi-Lineage Dysplasia (MDS-MLD)
  • Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)
    • Single Lineage Dysplasia
    • Multi-Lineage Dysplasia
  • Myelodysplastic Syndrome with Excess Blasts (MDS-EB)
    • MDS-EB-1
    • MDS-EB-2
  • Myelodysplastic Syndrome with Isolated del(5q) – (5q Minus)
  • Myelodysplastic Syndrome, Unclassifiable – (MDS-U)
    • with 1% PB blasts
    • with SLD and pancytopenia
    • with MDS defining cytogenetic abnormality

Definitions
  • Dysplasia Characteristics
  • Cytopenia Definitions
  • MDS Cytogenetics
Other
  • Myelofibrosis – Etiologies

References

Swerdlow SH, Campo E, Harris, NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds):  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). IARC: Lyon 2017

Share this:

  • Share on X (Opens in new window) X
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Facebook (Opens in new window) Facebook
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
  • Share on LinkedIn (Opens in new window) LinkedIn

PathMD E-Mail Signup

Poll

What is your most commonly used breast specific IHC marker?
Results

Check-out more in-depth information on these markers the PathMD IHC section of our website/app.

Search PathMD

Important Links

Cancer Protocols

Am. Board of Path. 

PathMD Blog

PathMD
Proudly powered by WordPress